Both the American College of Cardiology and the American Heart Association voiced their public support this week for legislation that would expand access to cardiac and pulmonary rehabilitation services in the U.S.

A Portland-area cardiologist has been accused of implanting more than 100 patients with unnecessary pacemakers, incentivized by free travel and gifts from device sales representatives, the East Oregonian reports.

Nala, a Riyadh, Saudi Arabia-based digital health company, has launched a new AI platform for medical diagnosis. According to Nala, it is the first platform to provide users with diagnoses in Arabic.

Bystanders of out-of-hospital cardiac arrests are more likely to face legal consequences for delaying or failing to provide CPR than for damages incurred during a resuscitation attempt.

An increase in the proportion of millennials with chronic health conditions like high blood pressure, high cholesterol and depression could cost the U.S. economy in a big way, the Daily Mail reported Nov. 7.

PathAI, a Boston-based AI technology company focused on pathology solutions, announced it has raised $75 million in Series B funding.

Medicine is moving farther from its fee-for-service roots and closer to more individualized, value-based care—a phenomenon that could benefit a growing number of home-based care programs, according to data presented at MedAxiom’s CV Transforum.

The Food & Drug Administration issued a recall on Philips’ Forte Gamma Camera System Monday, Nov. 4, saying it could cause serious injury or possibly death.